GENE ONLINE|News &
Opinion
Blog

AI Drug
Insilico Makes its Biggest AI Deal Ever with Sanofi for Potential $1.2 Billion
2022-11-09
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
2022-03-24
VIRTUALMAN Breaking Barriers in Drug Development with AI Solutions
2021-08-05Partner
AI Technology Revamping Drug Development! VIRTUALMAN to Demonstrate Powerful Solutions in BIO Asia-Taiwan 2021
2021-07-15Partner
R&D
BioMarin Collaborates with Canadian Biotech for AI-based Drug Discovery
2020-11-22
Bayer Expands its Metastatic Breast Cancer Treatment
2020-09-18
Combating the Pandemic via AI and Diagnostics: Highlights from the “TAIWAN is Helping: AI x Pandemic Prevention Online Forum”
2020-08-11Partner
Transforming Healthcare Ecosystems with Artificial Intelligence
2020-07-14Partner
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
LATEST
Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
2023-03-22
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
2023-03-22
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
2023-03-21
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
Scroll to Top